EMA approved the administration of different vaccines against covid to the same person – SME.sk

AMSTERDAM. The European Medicines Agency (EMA) approved in a statement Tuesday the combination of vector and mRNA vaccines against individuals in individuals.

“Evidence from heterologous vaccination studies suggests that the combination of virus vector-based vaccines and mRNA vaccines produces good levels of antibodies to the disease-causing virus COVID-19 (SARS-CoV-2) and a higher immune response at the T-cell level than using the same vaccines (homologic vaccination), whether it is a primary vaccination or a booster regimen, “he writes on its EMA website.

Heterologous vaccination has been well tolerated by individuals in the research, the drug agency emphasizes.

Related article

Related article The WHO does not recommend treating covid with plasma from people who have overcome it Read

“The use of a viral vector vaccine as a second dose in a primary vaccination program, as well as the ingestion of two different mRNA vaccines, is less studied,” admits the EMA.

The EMA, together with the European Center for Disease Control (ECDC), recalled that such a strategy would give countries more options for administering vaccines, for example in the event of a specific unavailability of a specific vaccine.